scispace - formally typeset
M

Michael E. Hall

Researcher at University of Mississippi Medical Center

Publications -  154
Citations -  7407

Michael E. Hall is an academic researcher from University of Mississippi Medical Center. The author has contributed to research in topics: Heart failure & Blood pressure. The author has an hindex of 33, co-authored 145 publications receiving 4419 citations. Previous affiliations of Michael E. Hall include University of Mississippi & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.

Daniel Taliun, +205 more
- 10 Feb 2021 - 
TL;DR: The Trans-Omics for Precision Medicine (TOPMed) project as discussed by the authors aims to elucidate the genetic architecture and biology of heart, lung, blood and sleep disorders, with the ultimate goal of improving diagnosis, treatment and prevention of these diseases.
Journal ArticleDOI

Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

TL;DR: With prolonged obesity and development of target organ injury, obesity-associated hypertension becomes more difficult to control, often requiring multiple antihypertensive drugs and treatment of other risk factors, including dyslipidemia, insulin resistance and diabetes mellitus, and inflammation.
Posted ContentDOI

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Daniel Taliun, +194 more
- 06 Mar 2019 - 
TL;DR: The nearly complete catalog of genetic variation in TOPMed studies provides unique opportunities for exploring the contributions of rare and non-coding sequence variants to phenotypic variation as well as resources and early insights from the sequence data.
Journal ArticleDOI

Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease

TL;DR: The current understanding of M MP-9 physiology, including structure, regulation, activation, and downstream effects of increased MMP-9, is summarized.
Journal ArticleDOI

Obesity, hypertension, and chronic kidney disease.

TL;DR: Body weight reduction, via caloric restriction and increased physical activity, is an important first step for management of obesity, hypertension, and chronic kidney disease, however, this strategy may not be effective in producing long-term weight loss or in preventing cardiorenal and metabolic consequences in many obese patients.